Winslow Garrett
Damora Therapeutics, Inc. · General Counsel
Winslow Garrett is listed in filings as General Counsel at Damora Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 25, 2026, including sale activity. Recent filings connect the profile to Damora Therapeutics, Inc. (DMRA) and Galecto, Inc. (GLTO). The current snapshot covers public activity from Oct 11, 2024 to Mar 25, 2026. Reported amounts are shown as $5.8M to $881. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $881260 shares | SellJul 3, 2025 | $3.39 | $21.58 | |
| $2.6k471 shares | SellJan 3, 2025 | $5.60 | $21.58 |